MAYADAGLI, AlparslanKiziltan, HURİYE ŞENAYBayir, Ayse GunesTAŞPINAR, OzgurMeral, IsmailEris, ALİ HİKMETDEMİRTAŞ, MuratAydin, TEOMAN2019-10-052019-10-052014-01-01Kiziltan H. Ş. , Bayir A. G. , DEMİRTAŞ M., Meral I., TAŞPINAR O., Eris A. H. , Aydin T., MAYADAGLI A., -Ascorbic-acid Treatment for Progressive Bone Metastases After Radiotherapy: A Pilot Study-, ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, cilt.20, ss.16-20, 2014https://hdl.handle.net/20.500.12645/1666Context Researchers have reported improved survival rates for patients with cancer when 10-75 g of vitamin C (ascorbic acid, or AA) is administered intravenously. AA exhibits a cytotoxic effect upon entering a cancer cell.enAscorbic-acid Treatment for Progressive Bone Metastases After Radiotherapy: A Pilot StudyArticleWOS:000348881500004